BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Policy

  pSivida Corp Announces Resubmission Of New Drug Application For ILUVIEN®

  March 27, 2014

   · 

  1 min read
• BioMidwest

  EXACT Sciences Corporation’ Stock Trading Halted Today; FDA Advisory Committee Meeting To Review Premarket Approval Application

  March 27, 2014

   · 

  1 min read
• Drug Development

  bluebird bio Announces First Patient Transplanted In Phase 1/2 Northstar Study For The Treatment Of Beta-Thalassemia

  March 27, 2014

   · 

  1 min read
• Policy

  CytRx Corporation Issues Statement Regarding Recent Lawsuits

  March 27, 2014

   · 

  1 min read
• BioForest

  Takeda Pharmaceutical Co. Ltd. Presents Additional Data From The EXAMINE Cardiovascular Safety Outcomes Trial At The American College of Cardiology’s 63rd Annual Scientific Session

  March 27, 2014

   · 

  14 min read
• Biotech Bay

  OXiGENE Announces Presentation Of Three Preclinical Abstracts At 2014 American Association for Cancer Research Conference

  March 27, 2014

   · 

  1 min read
• Drug Development

  Cempra To Present Late-Breaker On Solithromycin Reducing Inflammation In An Animal Model For Cancer Chemotherapy-Induced Lung Injury

  March 27, 2014

   · 

  1 min read
• Biotech Beach

  ArtVentive Medical Group, Inc. Announces New Catheter-Assisted Endovascular Tumor Treatment System

  March 27, 2014

   · 

  1 min read
• VeriTeQ Corporation Rebrands Its “Q Inside Smartmarker” To Lead Its Radiation Dosimetry Business; Q Inside Smart Marker Is World’s First Implantable Sensor Cleared By FDA To Measure Radiation Dose Directly At The Tumor Site

  March 27, 2014

   · 

  1 min read
• Pharm Country

  Plandai Biotechnology, Inc.'s Human Clinical Trials Offer Significant Proof Of Concept

  March 27, 2014

   · 

  2 min read